Miochol-E Related Published Studies
Well-designed clinical trials related to Miochol-E (Acetylcholine)
Quantification of eccrine sweat glands with acetylcholine sweat-spot test and anatomical redistribution of sweating after T2-T3 thoracoscopic sympathicolysis. [2009.02]
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. [2008.09.15]
Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed. [2008.08]
Nicotinic acetylcholine receptor {beta}2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. [2008.07.01]
M2 and M3-muscarinic acetylcholine receptors remodelling in patients with a dilated atrium. [2008.04]
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. [2007.06]
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. [2007.06]
Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI). [2007.03]
Well-designed clinical trials possibly related to Miochol-E (Acetylcholine)
The facilitatory effects of intermittent theta burst stimulation on corticospinal excitability are enhanced by nicotine. [2009.08]
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. [2009.07.23]
Varenicline reduces alcohol self-administration in heavy-drinking smokers. [2009.07.15]
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. [2009.07]
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. [2009.07]
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. [2009.07]
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. [2009.07]
Electroencephalographic effects of galantamine in major depressive disorder. [2009.06]
Impaired off-line consolidation of motor memories after combined blockade of cholinergic receptors during REM sleep-rich sleep. [2009.06]
A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction. [2009.05.05]
L-arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease. [2009.05]
Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. [2009.04.28]
Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. [2009.04.28]
A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia. [2009.04]
Varenicline for smoking cessation: a placebo-controlled, randomized study. [2009.04]
Varenicline for smoking cessation: A placebo-controlled, randomized study. [2009.01.23]
Varenicline improves mood and cognition during smoking abstinence. [2009.01.15]
Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. [2009.01]
Cholinergic enhancement reduces spatial spread of visual responses in human early visual cortex. [2008.12.10]
Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. [2008.12]
The vascular effects of rotigaptide in vivo in man. [2008.11.15]
Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease. [2008.10]
Role of nitric oxide in the visible light-induced rapid increase of human skin microcirculation at the local and systemic level: I. diabetic patients. [2008.10]
The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens. [2008.09.15]
Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. [2008.09]
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. [2008.08.05]
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. [2008.08]
Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. [2008.08]
The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens. [2008.07.24]
A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. [2008.07.11]
Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. [2008.07]
Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. [2008.07]
Adverse cardiovascular effects of acute salt loading in young normotensive individuals. [2008.06]
Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. [2008.05.06]
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. [2008.05]
Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans. [2008.05]
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. [2008.05]
Impact of pioglitazone on coronary endothelial function in non-diabetic patients with coronary artery disease. [2008.04.24]
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. [2008.04]
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. [2008.04]
Cholinergic gating of improvement of tactile acuity induced by peripheral tactile stimulation. [2008.03.21]
Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. [2008.03]
Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin. [2008.03]
Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes. [2008.03]
Intra-arterial vitamin C prevents endothelial dysfunction caused by ischemia-reperfusion. [2008.03]
Selective Effects of Cholinergic Modulation on Task Performance during Selective Attention. [2008.03]
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. [2008.02]
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. [2008.02]
Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes. [2008.02]
Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. [2008.01]
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms. [2008.01]
Pathophysiology and treatment of psychosis in Parkinson's disease: a review. [2008]
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone. [2008]
Gene-environment interactions in the development of combined type ADHD: evidence for a synapse-based model. [2007.12.05]
Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries. [2007.12.01]
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes. [2007.12]
Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat. [2007.11]
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. [2007.11]
Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia. [2007.10]
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease. [2007.10]
Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. [2007.09]
Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans. [2007.09]
[Clinical study on effect of Shenyin Oral Liquid in treating mild cognitive impairment] [2007.09]
Persistent endothelial dysfunction in humans after diesel exhaust inhalation. [2007.08.15]
Galantamine treatment of vascular dementia: a randomized trial. [2007.07.31]
Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men. [2007.07]
Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction. [2007.07]
Intragastric injection of botulinum toxin A for the treatment of obesity. [2007.06]
Inhibition of release of vasoactive and inflammatory mediators in airway and vascular tissues and macrophages by a chinese herbal medicine formula for allergic rhinitis. [2007.06]
An alternative agent for radial arterial graft spasm: application of topical iloprost. [2007.06]
Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells. [2007.06]
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. [2007.06]
Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect. [2007.05]
Relationship between vascular reactivity and lipids in Mexican-Americans with type 2 diabetes treated with pioglitazone. [2007.04]
Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. [2007.03.27]
Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. [2007.03]
Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. [2007.02]
Hyperoxia attenuates endothelial-mediated vasodilation in the human skin. [2007.02]
Acute effects of triiodothyronine on endothelial function in human subjects. [2007.01]
Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade. [2007]
Other research related to Miochol-E (Acetylcholine)
Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. [2009.12.26]
Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. [2009.10.12]
A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. [2009.10.01]
Alpha9 nicotinic acetylcholine receptors and the treatment of pain. [2009.10.01]
Association learning-dependent increases in acetylcholine release in the rat auditory cortex during auditory classical conditioning. [2009.10]
Dissociating beta-amyloid from alpha 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes alpha 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain. [2009.09.02]
Acetylcholine receptor pathway and lung cancer. [2009.08]
Central acetylcholinesterase inhibition improves hemodynamic counterregulation to severe blood loss in alcohol-intoxicated rats. [2009.08]
Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite. [2009.07]
Consumption of a high-fat diet in adulthood ameliorates the effects of neonatal parathion exposure on acetylcholine systems in rat brain regions. [2009.06]
Kinetics of desensitization and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells. [2009.06]
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. [2009.06]
Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor. [2009.05]
|
